The LVMH Watch Week is around the corner ✓ We have picked five highlights from LVMH brands from 2025 ✓ Check them out ✓ ...

This was the stock's sixth consecutive day of losses.

Key Insights Using the 2 Stage Free Cash Flow to Equity, Vertex fair value estimate is US$32.91 Vertex's US$19.50 ...

ISE 2026 is coming, set to open its doors on Feb. 3 at Fira de Barcelona. To prepare you for the show, SCN is bringing you ...

On Jan. 12 Five9 announced an expanded partnership with Google and a new joint Enterprise CX AI solution targeting large ...

The updates make videos more expressive and creative with simple prompts, add native vertical video support in 9:16 aspect ...

Abu Dhabi successfully completes its first gene therapy for genetic blood disorders, revolutionizing treatment approaches for ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...

As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...

Vertex Pharmaceuticals has several growth drivers in the new year. Enbridge offers stability in the event the economy declines over the next 12 months. Some kiss a loved one at midnight on New Year's ...

UTime ( ($WTO) ) has provided an announcement. On December 31, 2025, UTime Limited announced that its Hong Kong subsidiary, UTime Technology (HK) ...